Clinical Trial Update: Liposomal Bupivacaine in Implant Based Breast Reconstruction [NA]

View source ↗

Summary

Clinical trial update for liposomal bupivacaine in implant-based breast reconstruction; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Postoperative Pain

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Loma Linda University | Conditions: Breast Cancer, Postoperative Pain | NA | Status: TERMINATED | Results posted: 2019-08-21